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The development of patient communication tools in 
health services research often requires the skills of 
a designer who will give the tool its final, usable form. 
However, research teams frequently overlook the 
demands of implementation and focus instead on the 
delivery of content to the patient. In the study considered 
here, shared decision making in cancer treatment, 
research was initiated by an interdisciplinary team without 
the participation of a designer. Once a designer began 
working on the team, the benefits he/she brought to 
the production of the designed artefact were evident. 
Design improved the team’s effectiveness through 
better communication, and allowed for further studies 
based on application and theory. Researchers responded 
positively to design and saw the potential for its 
application to a range of health research.
1. Background
This project came about at the invitation of a bio‐ethicist, 
a bio‐informatics scholar, and a cancer researcher and 
clinician. The oncologist Dr. Larry Cripe is the primary 
investigator, and the impetus of this project is his 
experience in the clinic. Dr. Cripe and his team had been 
working on a decision‐making tool (the Roadmap) for 
patients with acute myeloid leukemia (AML), a form of 
cancer most commonly found in 70 and 70+-year-old 
individuals (MedLine Plus 2017). The initial design 
challenge of this project was the creation of a tool to 
facilitate patient-decision making. Decision aids are 
becoming increasingly prevalent in medicine due to 
greater emphasis on doctor‐patient communication to 
shift treatment priorities toward more patient‐centred 
outcomes (Ernecoff et al. 2016). Many projects, includ-
ing this one, are intended for screen‐based media, to 
facilitate decision‐tree interactivity.
Dr. Cripe is frequently faced with the task of 
delivering the initial cancer diagnosis to his patients and 
presenting them with a range of treatment choices. For 
patients in the advanced stages of the disease, Dr. Cripe 
also presents the option of supportive care, which 
focuses on providing comfort to the patient rather than 
disease control.
Patient‐oncologist communication have multiple 
goals: exchanging information, building relationship, 
making decisions, and supporting patients emotionally 
(Arora 2003). The available evidence suggests that 
oncologists struggle to achieve these goals, especially 
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when the outlook for the patient is poor and death is the 
most likely outcome. Several factors can hinder effective 
communication. In this project it was the difficulty 
of providing patients with information relevant to 
their decisions that hindered effective communication. 
Multiple studies of patients have demonstrated that 
patients quickly feel overwhelmed by the volume 
and complexity of information and often recall only a 
small fraction of the potentially relevant information. 
Therefore, the original aim was to develop a more 
efficient means to disclose the necessary information 
and a means to disclose information in a way that 
would support patient decision making. The perceived 
benefits of a more efficient means of disclosure include 
more accurate patient recall and increased time for the 
oncologist to provide emotional support and discuss how 
decisions are made to assure the decisions are consistent 
with patients’ fully‐informed preferences.
2. Shared understandings
The clinical experience of the physicians on the team, 
which was also reflected in the literature, suggested 
the following:
1. Qualitative studies of patient experience reveal that 
patients do not identify as important the elements 
of shared decision making valued by physicians 
(Koehler, Koenigsmann, & Frommer 2008).
2. Patients tend to trust the expertise of the physician 
and feel that only through them they can get a better 
treatment (Nissim).
3. Patients believe that the desire to live and the urgency 
of the diagnosis lead them to devalue information 
and accept the physician’s recommendation without 
much evaluation (Leppin et al. 2017).
4. Patients demonstrate poor recall and feelings of being 
overwhelmed (Nissim).
3. Problem definition
During the design process, we found that progress was 
being delayed by lack of focus and weak continuity 
between meetings. Our concern as designers therefore 
was team mechanics: without clear communication 
within the team, we could not move forward with the 
design. After two meetings, it became clear that there 
was no shared model for the project at hand. When 
asked why he had asked designers to join the research 
team, the PI/oncologist on the project answered: “We 
were stuck” (Larry Cripe, personal email, June 12, 2017).
3.1 Framework
At the beginning of the project, the doctors used an 
unstated framework based on their content knowledge 
and desire to make an artefact, specifically, a decision tool 
in the form of a touch-screen app. Based on previous 
knowledge, largely first hand and experiential knowledge, 
according to Dr. Cripe the initial framework for the 
project looked like the example depicted in Figure 1.
DOCTORS
Problem definition
“How might we improve patient experience based on 
these 4 situations?”
Patient knowledge
Through lens of doctor
Patients weigh their decisions based on  
(1) Risk, (2) Uncertainty, (3) Values, (4) Goals
Two patient groups, treatable and palliative
Theoretical framework
Bioethical principles
Figure 1. Study framework with medical considerations only
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The creation of artefacts through the design process 
led to the emergence of another framework (Figure 2) 
that integrated perspectives outside those brought by 
the doctors.
4. Methodology & design process to 
develop the solution
 – “What are you doing here?” Member of study team, 
medical anthropologist
 – “I’m making the ‘thing’.” Member of study team, 
designer
At the initial meeting, it became clear that the team 
was tangled in their own content and had not looked 
at user input for direction. Fortunately, audio tapes of 
several patient consultations were available. With this 
patient data, and the information obtained through 
informal interviews with Dr. Cripe and his clinical team, 
we were able to design a patient experience map.
4.1 Map
The map traces patients’ experience over time from the 
onset of symptoms through inpatient therapy to their 
release home. It shows doctor/patient interactions and 
patients’ thoughts and emotions triggered by communi-
cation with the doctor (Figure 3).
By revealing the experience of the patient, the map 
brought a new form of knowledge to the project, and 
in doing so, validated the design process. The team 
had approached the experience of the patient only 
through the experience of the oncologist during office 
visits. The map enabled the team to engage with each 
other through the patient experience as it progressed 
over stages. The map also provided a shared framework 
for discussion of the broader themes that had already 
emerged in the pre‐design integration stage, such as 
physician trust. Critique of the map gave the interdisci-
plinary team specific points to focus on.
4.2 Worksheets/simulations
Worksheets were to be used during office visits to aid 
with the retention of information, and as a tool for 
general reference/information while treatment decisions 
were being made. Content was initially conceived by the 
oncologist based on experience. Later, however, content 
was modified significantly based on role-play simula-
tions of patient visits, in which members of the study 
team unfamiliar with AML played the role of patient 
and family member, with the oncologist proceeding as 
in standard appointments. Worksheets were initially 
designed to ensure that the patients could discuss the 
DOCTORS DESIGNER
Problem definition
“How might we improve 
patient experience based 
on these 4 situations?”
“How might we collaborate 
with medicine to improve 
patient experience?”
Patient knowledge
Through lens of doctor No knowledge
Patients weigh their 
decisions based on  
(1) Risk, (2) Uncertainty, 
(3) Values, (4) Goals
Two patient groups, 
treatable and palliative
Theoretical framework
Bioethical principles User-centred principles
Figure 2. Study framework integrating perspectives outside 
those brought by the doctors
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issues they wanted during their appointment (agenda); 
understood their treatment options and potential 
side-effects; and were informed of options at different 
decision points in their treatment.
The simulations had a marked effect on the concep-
tion of the worksheets. The original intent was for the 
worksheets to efficiently share materially important 
information with the patient, with informed consent (i.e., 
permission for treatment) and shared decision making 
as the dominant paradigms. The worksheets were to 
serve as neutral ground between oncologist and patient 
and provide the patient with an informative document 
they could take away with them. The content was generic 
information (e.g. “What is AML?”); patient‐specific 
information (e.g. test results and an explanation of what 
they mean: “here is how we know you have AML”); and 
communicating the implications (prognosis: “You have 
AML and you are likely to be cured (or die).”)
The simulations, first and foremost, convinced us 
that the efficient transfer of complicated, voluminous, and 
threatening information is not possible. Although we 
progressively refined and limited the amount of informa-
tion, patients in our simulations were still overwhelmed 
in the first few minutes of the conversation. We also 
learned that the content on the worksheet may distract 
patients, so we are working on how to integrate the 
worksheet without taking the patient’s attention away 
from what is being said during the conversation.
All in all, our user‐centred approach to worksheet 
development has led us to focus on process rather than 
outcomes. Rather than trying to provide the patient 
prognostic estimates we are training the patient and 
Figure 3. Patient Experience Map
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oncologist so that they know how to navigate together 
whatever happens in the future. Thus, instead of trying 
to reassure people that their chance of dying is too low 
to worry about, or trying to caution people that their 
chance of dying is so high that any treatment would likely 
be ineffective or could make them feel worse, we are say-
ing let’s figure out how to navigate the future regardless 
of the outcome. We are exploring narrative techniques 
to identify bigger themes that can help patients come to 
an understanding of their illness on their own terms, so 
that rather than focussing on AML they can focus on 
themselves, their priorities, and their lives. In essence, 
our focus shifted from creating an AML Road Map to be 
followed, to creating a patient‐traveller, better equipped 
to make decisions confidently along their journey.
4.3 Process
Our working method is a hybrid process that reflects 
the doctors’ content expertise and the process expertise 
of the design team (see Figures 5 and 6). Once again, 
the underlying platform for progress is an artefact, 
Figure 4. Worksheet example
Key Questions
MY AML ROAD MAP Goals for Treatment & Care Option Grid
Treatment
Goals for Treatment & Care
Care
What does it mean?
Normal blood counts A cure is when there’s a
complete remission for
ve years or longer.
Your quality of life is the
extent to which your life
is satisfying, enjoyable or
meaningful.
Personal goals reect who
you are and what you hope
to achieve in the future.
We will think about your
quality of life in terms of
how you feel physically and
emotionally.
Intensive inpatient induction
chemotherapy
Further intensive
chemotherapy
In order to provide you
with the best quality of life,
we will work together to
identify and respond to 
distressing physical and
emotional symptoms.
Start by engaging in
personal reection and
talking with family and 
friends about what’s
important to you.
Next, we will discuss your
personal goals and decide
how best to align them with
your treatment goals.
Care directed at symptoms
is called supportive or
palliative care. you will
receive palliative care
wether or not you choose
chemotherapy.
Allogeneic stem cell
(bone marrow) transplant
Less intensive outpatient
induction chemotherapy
Clinical trials may be an
option
No blasts in the blood
Less than 5% blasts in
the bone marrow
Feeling well
Achieving
Complete Remission
Achieving
Cure
Achieving
Personal Goals
Optimizing
Quality of Life
How is this achieved?
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increasingly the site of patient/doctor communication, a 
hardcopy tool that adds a visual component to the doc-
tor’s appointment, currently delivered face‐to‐face with 
visual aids. Both doctors and designers had intended on 
employing a design process in the study, the key differ-
ence being the patient journey research and exposition.
5. Evaluation/impacts
We are currently in the design development/testing 
stage of the doctor/patient intervention, so evaluation 
of the tool in use is still ahead of us. So far, however, the 
design process itself has taught us two things that have 
implications for design research: 1) that a design-centred 
intervention can be a generative model for Basic/Applied 
research, and 2) that design-centred processes that bring 
teams together around designed things (“thingness”) 
facilitate generative interdisciplinary discourse within 
academic teams.
5.1 Intervention‐centred model for basic/
applied research
Since the start of our involvement with the project, the 
study team has consistently spun off a range of questions 
touching upon each of the disciplines represented in the 
team. This has led to an understanding of this study as 
a generator of not one but two distinct paths of inquiry, 
Basic and Applied, wherein ‘Basic Research’ is research 
without a specific application in mind, and ‘Applied 
Research’ is conducted to address a practical problem. 
This split understanding is one of the contributions of 
our work.
The Applied path relates to the refinement and 
efficacy of the patient intervention itself. Intervention 
development (the AML Road Map) was initially 
conceived as the sole aim of the project. Significantly, 
because the project centred around the production 
of an artefact/object rather than the generation of 
Figure 5. Doctor process vs design process Figure 6. Our hybrid process (bold indicates 
completed steps)
DOCTOR DESIGNER
1. Gather user/patient data
2. Design patient 
experience map
3. Frame problem
1. Write decision aid content 4. Write content
2. Design decision aid artefact 5. Design artefact
3. Test 6. Test
4. Re‐design 7. Re‐design
5. Implement 8. Implement
6. Evaluate 9. Evaluate
Phase Effect on process
1. Patient data gathering (pre‐study)
2. Patient Experience Map Facilitated communication 
(un‐stuck team process); 
defined overall scope
3. Worksheet development Solution finding
4. Testing Checking effects, efficacy
5. Revision
6. A/B testing
7. Revision
8. Implementation
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new knowledge/scientific discovery, the project was 
not viewed as an act of research. We lacked a formal 
hypothesis, and without a strictly determined basis 
for establishing evidence, the design itself became 
the measure of progress. We applied best practices in 
graphic, service, and experience design, and assessed 
their efficacy with members of the study team. The 
scientific team fed into our work raw data from recorded 
patient consultations, their knowledge from cancer 
literature and from established principles of bioethics. 
We were guided by the questions “Are we doing the right 
thing?” and “Are we doing it in the best possible way?”.
The Basic path was an emerging area of general 
inquiry that was identified at every stage of review. 
Questions such as “What is the impact of negative 
health news on comprehension of information?” stood 
as potential areas for further theoretical inquiry and 
speculation, related to but beside the original intent of 
the project. Questions such as this suggest the integra-
tion of additional disciplines into our inquiry (such as 
health communication), and open the door for research 
in other fields. The Applied activities ‘spin off ’ Basic 
lines of inquiry for research/knowledge generation, and 
have the potential to pull other fields into discourse, 
facilitated by design. We intend to address the ‘Basic’ 
area separately and are keeping track of its implications 
for research as we make the artefact.
5.2 The significance of things
Both the efficacy of the intervention in the Applied path 
and interdisciplinary integration of the Basic track rely 
on the persistence of the object. Perhaps the first notable 
outcome of the AML Road map intervention is how the 
introduction of a physical object impacted the team. The 
design became the locus of attention, discussion, deci-
sion‐making, and idea generation. The physical presence 
of a visual object, rather than being viewed on screen, 
had a galvanizing effect on our research partners, po-
tentially because deliberate engagement with the object 
through sight and touch provided a common reference 
point regardless of specialization. We believe that it is 
stimulating for research teams to create interventions 
governed by design processes rather than solely through 
content knowledge. This is because the physicality of the 
object directs attention away from disciplinarity (silo-ed, 
specialized, or disease-centred ways of thinking) and 
toward utility and patient perspectives. We also speculate 
that embodying disciplinary knowledge in a tool is a 
novel way for many researchers to engage their expertise. 
The significance of the “thingness” seems to suggest an 
alternative approach to design. One which considers 
the design process design “thinging” rather than “design 
thinking”, which emphasizes engagement with design 
to make ideas manifest and accessible. The extent to 
which design can provide a platform for discourse is a 
significant ‘Basic’ research question we hope to explore 
in ongoing research.
6. Implications for design education 
and practice
Often designers enter into collaborative projects with the 
understanding that the end outcome or artefact is their 
primary output. This project suggests that the benefits of 
design emerge much earlier in the process, through its 
impact on team efficiency in terms of communication 
and its potential to extend and refine questions of 
application and basic research.
Implications for design education and for design 
practice carry into the self‐conception of the designer/
design identity. I would like to suggest that design 
focused on the end‐user brings opportunities for 
team‐building and disciplinary innovation specifically 
because the disciplines take a ‘back seat’ to the user 
experience. Rather than creating a vessel into which 
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silo-ed researchers pitch‐in to create a more comprehen-
sive carrier of disciplinary content, the design process 
creates a more communicative, better coordinated team 
by shifting the focus from content to context, and from 
comprehensive coverage to effectiveness. Implications 
for design education are clear: in addition to competency 
in design methods and best practices, designers also 
need to be prepared to work in interdisciplinary teams 
as ‘ring‐leaders’ or ‘shepherds,’ engaged in acts of 
creating that reel people in, scoop up stragglers, appoint 
or propose tasks, and keep everyone going in the same, 
shared direction. Replication of design’s capacity to 
fashion better communication and better interventions 
depends on fidelity to design methods in research and 
design methods in craft. One of the most basic and 
broadest goal of design education is to attain mastery of 
the practice, and this is still essential for working with 
interdisciplinary teams. It is imperative that the design’s 
functionality reflects both the research interests of the 
team and the perspective of the user. To this capacity 
I would add the importance of awareness of design’s 
‘thingness’ as a galvanizing force for communication 
across disciplines (Frascara & Noël 2014). If a designer 
wants to make a big impact on research they need to 
be able to see design as an external force that disrupts 
disciplinary inquiry to focus on relevance while expand-
ing horizons for interdisciplinary practice.
7. Conclusion
As design thinking infiltrates both medical education 
and research, designers must keep in mind that the tools 
they bring along with them should not be relegated 
to either crafting deliverables or facilitating processes 
of innovation and iteration. Design can help engage 
researchers in their disciplines in new ways. It enables 
researchers to draw upon their expertise in the creation 
of a patient-centred tool, rather than erect an edifice of 
expertise, centred on validating its own authority. This 
is perhaps the longest standing contribution design can 
make to research. Designed products can help experts 
talk to each other confidently and without reservations.
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